Skip to main content
. Author manuscript; available in PMC: 2018 Jan 24.
Published in final edited form as: Mol Imaging Biol. 2017 Oct;19(5):772–778. doi: 10.1007/s11307-017-1052-3

Table 2.

Sources derived from SBM analysis significantly different among the studied groups (PD vs CG).

Component Direction Cluster Region MNI mm3
8 PD<CG 1 Putamen L −24, 0, +2 8300
2 Putamen R +22, +4, +2 9400
3 Caudate L −12, +14, +2 2400
4 Caudate R +12, +12, +2 3700
5 Insula L −36, 0, +2 200
6 Insula R +36, 0, 0 500
7 Thalamus R +14, −6, +6 400
8 Anterior Cingulate L −12,+22, −4 100
9 Anterior Cingulate R +12, +22, −6 300
21 PD<CG 1 Putamen L −20, +8, +2 8100
2 Caudate L −14, +16, +2 3600
3 Insula L −36, −8, +8 1300
23 PD<CG 1 Putamen L −28, −6, +2 4700
2 Putamen R +26, −6, +4 3800
3 Insula L −36, −2, +2 1300
4 Insula R +36, −2, −2 200
5 Pons L −16, −14, −18 200
PD>CG 1 Pallidum L −12, +2, −4 600
2 Pallidum R +14, +6, 0 1900
3 Thalamus L −12, −10, +16 1000
4 Thalamus R +14, −8, +14 800
5 Caudate L −8, +4, 0 300
6 Caudate R +12, −2, +18 1300
7 Medial Frontal gyrus R +8, +26, −20 300
8 Inferior Temporal gyrus L −40, −12, −34 100

PD: Parkinson’s Disease; CG: control group; MNI: Montreal Neurological Institute coordinates system; L: left; R: right; mm3: cluster dimension expressed in cubic millimeter.